Literature DB >> 520652

Hexopal in Raynaud's disease.

M Aylward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 520652     DOI： 10.1177/030006057900700602

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  3 in total

1.  A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.

Authors:  G T Sunderland; J J Belch; R D Sturrock; C D Forbes; A J McKay
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

Review 2.  Pharmacotherapy of Raynaud's phenomenon.

Authors:  J J Belch; M Ho
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 3.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.